LCM

Lynx1 Capital Management Portfolio holdings

AUM $346M
This Quarter Return
-24.44%
1 Year Return
-2.97%
3 Year Return
+1,498.67%
5 Year Return
–
10 Year Return
–
AUM
$108M
AUM Growth
+$108M
Cap. Flow
+$20.1M
Cap. Flow %
18.66%
Top 10 Hldgs %
98.47%
Holding
14
New
4
Increased
6
Reduced
3
Closed
–

Top Buys

1
PRDS
Pardes Biosciences, Inc. Common Stock
PRDS
$8.96M
2
KNTE
Kinnate Biopharma Inc. Common Stock
KNTE
$7.8M
3
BLU
BELLUS Health Inc.
BLU
$5.84M
4
MRUS icon
Merus
MRUS
$2.91M
5
PVLA
Palvella Therapeutics, Inc. Common Stock
PVLA
$2.28M

Top Sells

1
TVTX icon
Travere Therapeutics
TVTX
$8.39M
2
IMGN
Immunogen Inc
IMGN
$2.79M
3
THRX
Theseus Pharmaceuticals, Inc. Common Stock
THRX
$606K

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
MRUS icon
1
Merus
MRUS
$4.98B
$23.6M 21.94%
893,527
+110,129
+14% +$2.91M
BLU
2
DELISTED
BELLUS Health Inc.
BLU
$19.6M 18.22%
2,851,588
+848,474
+42% +$5.84M
ALPN
3
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
$13.3M 12.37%
1,484,693
+222,766
+18% +$2M
PRDS
4
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
$11.9M 11.01%
1,642,834
+1,241,241
+309% +$8.96M
TVTX icon
5
Travere Therapeutics
TVTX
$1.56B
$10.6M 9.85%
411,680
-325,381
-44% -$8.39M
KNTE
6
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$7.8M 7.24%
+692,508
New +$7.8M
IMGN
7
DELISTED
Immunogen Inc
IMGN
$7.35M 6.82%
1,543,259
-586,272
-28% -$2.79M
CBAY
8
DELISTED
Cymabay Therapeutics
CBAY
$4.32M 4.01%
1,388,505
+163,537
+13% +$509K
THRX
9
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
$4.11M 3.82%
356,827
-52,531
-13% -$606K
PVLA
10
Palvella Therapeutics, Inc. Common Stock
PVLA
$599M
$3.44M 3.2%
1,136,319
+753,053
+196% +$2.28M
JBIO
11
Jade Biosciences, Inc. Common Stock
JBIO
$258M
$1.23M 1.14%
+66,977
New +$1.23M
PASG icon
12
Passage Bio
PASG
$22.7M
$327K 0.3%
+105,504
New +$327K
OTIC
13
DELISTED
Otonomy, Inc.
OTIC
$72K 0.07%
30,000
– –
ELEV
14
DELISTED
Elevation Oncology
ELEV
$25K 0.02%
+10,000
New +$25K